Aspergillus Serologic Findings and Clinical Outcomes in Patients With Bronchiectasis: Data From the European Bronchiectasis Registry

Autor: Pollock, J., Goeminne, P.C., Aliberti, S., Polverino, E., Crichton, M.L., Ringshausen, F.C., Dhar, R., Vendrell, M., Burgel, P.R., Haworth, C.S., De Soyza, A., De Gracia, J., Bossios, A., Rademacher, J., Grünewaldt, A., McDonnell, M., Stolz, D., Sibila, O., van der Eerden, M., Kauppi, P., Hill, A.T., Wilson, R., Amorim, A., Munteanu, O., Menendez, R., Torres, A., Welte, T., Blasi, F., Boersma, W., Elborn, J.S., Shteinberg, M., Dimakou, K., Chalmers, James D., Loebinger, M.R.

Publikováno v: In Chest

Targeting neutrophil serine proteases in bronchiectasis.

Autor: Chalmers JD; Division of Respiratory Medicine and Gastroenterology, University of Dundee, Dundee, United Kingdom.; These two authors are joint first authors., Mall MA; Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany marcus.mall@charite.de.; German Center for Child and Adolescent Health (DZKJ), partner site Berlin, Berlin, Germany.; German Center for Lung Research (DZL), associated partner site Berlin, Berlin, Germany.; These two authors are joint first authors., Chotirmall SH; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.; Department of Respiratory and Critical Care Medicine, Tan Tock Seng Hospital, Singapore., O'Donnell AE; Georgetown University Medical Center, Washington, DC, USA., Flume PA; Medical University of South Carolina, Charleston, SC, USA., Hasegawa N; Department of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan., Ringshausen FC; Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School (MHH), Hannover, Germany.; Biomedical Research in End-Stage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.; European Reference Network on Rare and Complex Respiratory Diseases (ERN-LUNG), Frankfurt, Germany., Watz H; Velocity Clinical Research Grosshansdorf, formerly Pulmonary Research Institute at LungenClinic Grosshansdorf, Airway Research Center North (ARCN), German Center for Lung Research Grosshansdorf (DZL), Grosshansdorf, Germany., Xu JF; Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, Institute of Respiratory Medicine, School of Medicine, Tongji University, Shanghai, China., Shteinberg M; Lady Davis Carmel Medical Center, Haifa, Israel.; The B. Rappaport Faculty of Medicine, Technion Institute of Technology, Haifa, Israel.; These two authors are joint senior authors., McShane PJ; University of Texas Health Science Center at Tyler, Tyler, TX, USA.; These two authors are joint senior authors.

Publikováno v: The European respiratory journal [Eur Respir J] 2024 Nov 21. Date of Electronic Publication: 2024 Nov 21.

Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis with Mildly Decreased and Normal Lung Function: A Real-Life Observational Study.

Autor: Yaacoby-Bianu K; Carmel Medical Center Technion - Israel Institute of Technology Haifa, Israel., Dagan A; Sheba Medical Center Ramat Gan, Israel., Cohen-Cymberknoh M; Hadassah Medical Center Hebrew University of Jerusalem Jerusalem, Israel., Tsviban L; Schneider Children's Medical Center Petah Tikva, Israel., Gur M; Technion - Israel Institute of Technology Haifa, Israel.; Rambam Health Care Campus Haifa, Israel., Golan-Tripto I; Soroka University Medical Center Beer-Sheva, Israel., Aviram M; Soroka University Medical Center Beer-Sheva, Israel., Stein N; Carmel Medical Center Technion - Israel Institute of Technology Haifa, Israel., Shteinberg M; Carmel Medical Center Technion - Israel Institute of Technology Haifa, Israel., Kerem E; Hadassah Medical Center Hebrew University of Jerusalem Jerusalem, Israel., Livnat G; Carmel Medical Center Technion - Israel Institute of Technology Haifa, Israel.

Publikováno v: Annals of the American Thoracic Society [Ann Am Thorac Soc] 2024 Nov; Vol. 21 (11), pp. 1620-1623.

Patient-managed interventions for adults with bronchiectasis: evidence, challenges and prospects.

Autor: Spinou A; School of Life Course and Population Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK arietta.spinou@kcl.ac.uk.; King's Centre for Lung Health, King's College London, London, UK., Lee AL; Department of Physiotherapy, Faculty of Medicine, Nursing and Health Sciences, Monash University, Frankston, Australia.; Institute for Breathing and Sleep, Austin Health, Heidelberg, Australia., O'Neil B; School of Health Sciences, Ulster University, Coleraine, UK., Oliveira A; School of Rehabilitation Sciences, Faculty of Health Sciences, McMaster University, Hamilton, ON, Canada.; West Park Healthcare Centre, Toronto, ON, Canada.; Lab3R - Respiratory Research and Rehabilitation Laboratory, School of Health Sciences, University of Aveiro (ESSUA), Aveiro, Portugal.; iBiMED - Institute of Biomedicine, Department of Medical Sciences, University of Aveiro, Aveiro, Portugal., Shteinberg M; Pulmonology Institute and Cystic Fibrosis Center, Carmel Medical Center and the Technion Israel Institute of Technology, the B. Rappaport Faculty of Medicine, Haifa, Israel., Herrero-Cortina B; Precision Medicine in Respiratory Diseases Group, Instituto de Investigación Sanitaria (IIS) Aragón, Zaragoza, Spain.; Universidad San Jorge, Zaragoza, Spain.

Publikováno v: European respiratory review : an official journal of the European Respiratory Society [Eur Respir Rev] 2024 Oct 30; Vol. 33 (174). Date of Electronic Publication: 2024 Oct 30 (Print Publication: 2024).

Clinical Efficacy of Serum Anti-glycopeptidolipid-core IgA Antibody Test for Screening Nontuberculous Mycobacterial Pulmonary Disease in Bronchiectasis: A European Multicenter Cohort Study.

Autor: Choi H; Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital, Seoul, Korea., Hughes C; Division of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom., Eke Z; Division of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom., Shuttleworth M; Division of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom., Shteinberg M; Pulmonology Institute and CF Center, Carmel Medical Center and the Technion - Israel Institute of Technology, the B. Rappaport Faculty of Medicine, Haifa, Israel., Polverino E; Hospital Clinic of Barcelona, Spain University of Barcelona, CIBERES, IDIBAPS, Barcelona, Spain., Goeminne PC; Department of Respiratory Disease, AZ Nikolaas, Belgium., Welte T; Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany., Blasi F; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Italy; Respiratory Unit and Cystic Fibrosis Center, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Milano, Italy., Shoemark A; Division of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom., Long MB; Division of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom., Aliberti S; Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20072, Pieve Emanuele, Milan, Italy; IRCCS Humanitas Research Hospital, Respiratory Unit, Via Manzoni 56, 20089, Rozzano, Milan, Italy., Haworth CS; Cambridge Centre for Lung Infection, Royal Papworth Hospital and University of Cambridge, Cambridge, United Kingdom., Ringshausen FC; Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany; Biomedical Research in End-Stage and Obstructive Lung Disease Hannover, German Center for Lung Research, Hannover, Germany; European Reference Network on Rare and Complex Respiratory Diseases, Frankfurt, Germany., Loebinger MR; Host Defence Unit, Department of Respiratory Medicine, Royal Brompton Hospital and Harefield NHS Foundation Trust, London, United Kingdom and NHLI, Imperial College London., Lorent N; Department of Respiratory Diseases, University Hospitals Leuven, Leuven, Belgium and Department of Chronic Diseases, Metabolism and Aging, BREATHE laboratory, KU Leuven, Leuven, Belgium., Chalmers JD; Division of Molecular and Clinical Medicine, University of Dundee, Ninewells Hospital and Medical School, Dundee, United Kingdom. Electronic address: jchalmers@dundee.ac.uk.

Publikováno v: Chest [Chest] 2024 Oct 25. Date of Electronic Publication: 2024 Oct 25.